Phase I, multicenter, open-label study of intravenous VCN-01 oncolytic adenovirus with or without nab-paclitaxel plus gemcitabine in patients with advanced solid tumors - Garcia-Carbonero, Rocio; Bazan-Peregrino, Miriam; Gil-Martin, Marta; Alvarez, Rafael; Macarulla, Teresa; Riesco-Martinez, Maria C; Verdaguer, Helena; Guillen-Ponce, Carmen; Farrera-Sal, Marti; Moreno, Rafael; Mato-Berciano, Ana; Victoria Maliandi, Maria; et al. (JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2022)